Moreover, a nomogram was constructed to predict the 1-, 3-, and 5-years survival probability of lung adenocarcinoma patients by combining the mRNA expression of ALDOA and clinical characteristics (Figure 6). This evidence concerns the gene ALDOA and lung adenocarcinoma.